SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : CANSLIM - COAST TO COAST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bruce A. Brotnov who wrote (5289)10/5/1999 6:49:00 PM
From: DanZ  Read Replies (1) of 6445
 
Bruce,

Thanks for looking at GumTech and for providing the EPS and RS data from IBD. I didn't expect that the EPS data would be very good since they lost money last year. I'm still curious if Mr. O'Neil would give a nod up for revenue growth, especially since their loss is decreasing. I agree that it would be better if they were already profitable, but the profits should come soon from two new major products that they are launching. One is Zicam, a cold remedy that has been shown through initial clinical research to reduce the duration of the common cold to 1.5 days, and the other is nicotine gum that will compete with Nicorette worldwide.

Best of luck with GTNR and thanks again for your comments.

Dan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News